Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule
Status:
Not yet recruiting
Trial end date:
2022-07-30
Target enrollment:
Participant gender:
Summary
A prospective, single-center, open-label, phase I study evaluating the pharmacokinetics (PK)
of human parathyroid hormone (1-34) ("PTH") administered via the RaniPill™ capsule
("RT-102").